Sandler Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $210K | Sell |
3,000
-1,000
| -25% | -$69.9K | 0.06% | 121 |
|
2025
Q1 | $294K | Hold |
4,000
| – | – | 0.07% | 97 |
|
2024
Q4 | $262K | Hold |
4,000
| – | – | 0.03% | 120 |
|
2024
Q3 | $312K | Hold |
4,000
| – | – | 0.04% | 109 |
|
2024
Q2 | $312K | Hold |
4,000
| – | – | 0.03% | 83 |
|
2024
Q1 | $271K | Hold |
4,000
| – | – | 0.02% | 97 |
|
2023
Q4 | $269K | Hold |
4,000
| – | – | 0.02% | 77 |
|
2023
Q3 | $271K | Hold |
4,000
| – | – | 0.03% | 67 |
|
2023
Q2 | $286K | Hold |
4,000
| – | – | 0.02% | 61 |
|
2023
Q1 | $278K | Hold |
4,000
| – | – | 0.03% | 59 |
|
2022
Q4 | $271K | Hold |
4,000
| – | – | 0.03% | 51 |
|
2022
Q3 | $219K | Buy |
+4,000
| New | +$219K | 0.03% | 55 |
|
2014
Q3 | – | Sell |
-532,000
| Closed | -$19.8M | – | 126 |
|
2014
Q2 | $19.8M | Buy |
+532,000
| New | +$19.8M | 0.83% | 22 |
|